Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The TRAIL study was conducted to examine the effects of escalating doses of an ACE inhibitor,
trandolapril, on lowering blood pressure in Stage 1-2 hypertensive patients.